Toshiba Enters Biochip Market With Novel Chip to Manage Hepatitis C | GenomeWeb

NEW YORK, Oct. 18 – Toshiba has entered the biochip arena by developing a DNA chip that it says can help researchers develop individual treatments for patients with hepatitis C, the company said on Thursday. 

The company said it planned to start marketing its pilot SNP-detection chip in fiscal 2002, which kicks off in April. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.